Treace Medical Concepts (TMCI) Assets (2020 - 2026)

Treace Medical Concepts (TMCI) has reported Assets for 7 consecutive years, with $181.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets fell 12.3% year-over-year to $181.1 million; the trailing twelve-month figure through Jun 2026 stood at $181.1 million (down 12.3% YoY), and the FY2025 full-year result was $190.6 million, down 12.21% from the prior year.
• Assets declined to $181.1 million in Q2 2026 per TMCI's latest filing, from $184.1 million in the prior quarter.
• Across five years, Assets topped out at $251.9 million in Q4 2023 and bottomed at $146.5 million in Q1 2022.
• Historically, Assets has averaged $204.2 million across 5 years, with a median of $206.1 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Assets surged 291.93% in 2022, then retreated 15.19% in 2025.
• Over 5 years, Assets stood at $159.0 million in 2022, then surged by 58.41% to $251.9 million in 2023, then decreased by 13.82% to $217.1 million in 2024, then fell by 12.21% to $190.6 million in 2025, then slipped by 5.0% to $181.1 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $181.1 million, $184.1 million, and $190.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.